E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter. When a new article is posted during the day, you will receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

Docs on Twitter

    follow me on Twitter

    Contact the Docs

    About the Authors

    • The Authors and Contributors of "Patent Docs" are patent attorneys and agents who hold doctorates in a diverse array of biotech and chemical disciplines.

    Disclaimer

    • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

    « Patent Profile: Ryogen Announces Issuance of Patent on Soluble Aminopeptidase P Gene | Main | IPO Releases Comments on New Markush Rules »

    October 29, 2007

    TrackBack

    TrackBack URL for this entry:
    http://www.typepad.com/services/trackback/6a00d83451ca1469e200e550513e498834

    Listed below are links to weblogs that reference GSK TRO/Preliminary Injunction Hearing :

    Comments

    Change is inevitable. Patent laws need to be changed as per the current requirement. If one honestly look at the recent patents, every one started claiming impurities, solvents, reagents, bases, anhydrous amorphous, solvate polymorph and useless peocess. These makes for all the products, time of patent expiry is getting extented. Thes makes other generic players to work with the non-infringing or novel process with the new reagents and no body know the toxicity in that process. Ultimately the patients are the sufferer, they don't get the cheaper generic medicine,if at all then with all the issues. These need to be addressed by supreme court. What is wrong to have Pre grant opposition for the patent . If there is value in the patent, definitely it will be granted. If it's something wrong, then these type of oppositon comes in their mind.
    For example a patent on Anhydrous amorphous fluvastatin patent is granted with out the specification on water of hydration for hydrated molecule and anhydrous moelcule.Also as on today the experts on polymorphs says that there is no anhydrous or molarity hydrated amorphous, amorphous is always an amorphous it could be hydrated or anhydrous. How can one person oppose the grnat of patent in the present system.

    How is he getting his BlackBerry/phone in? Doesn't this court not allow cell phones or electronic devices into the building?

    Dear Me:

    Some courts permit lawyers to bring them in (but not the public). Of course, he will need to be careful that it makes no noisy beeps or the court could make him leave. Alternatively, he could take notes during the hearing and upload them during any breaks.

    Couldn't someone call a friend, leave the phone turned on, and have the friend record the whole thing?

    I was wondering, if the patent office wants to cut down on continuations then why not just charge more for them? For example the first 2 continuations and 1 RCE might be at the current price, the next 2 at double that price, the next more expensive and so on. That would discourage people lodging them to some degree and also provide more funds to examine them. Companies like GSK wouldn't care about the fees, but the small entity inventor might get them cheaper.
    They could have also charged more for additional claims, to pay for extra staff.I suppose the real reason is that if they charged more then Congress would just take the extra money off them. So we get penalized because the PTO can't keep its fee increases.
    However that would reduce the backload of frivolous continuations, while allowing more valuable ones to still be filed.

    MJC,

    Stop talking sense.

    I find it ironic that the PTO claims that higher fees for more claims will not discourage applicants, yet filling out an ESD will....but the ESD is not a burden for the Good And True Applicant.

    That's an implicit admission that the true cost of the ESD is the sum of:
    (1) $$$ to prepare, plus
    (2) loss of patent value (i.e., loss of scope b/c of estoppel), plus
    (3) risk of inequitable conduct, plus
    (4) risk of atty sanctions iaw Mr. Moatz' recent tirades.

    Very interesting post on Kelley site on video provided in Tafas case as an exhibit. Appears the Deputy General Counsel of USPTO before retiring was willing to spill the beans with respect to the USPTO's true motive behind the vile rules. Short but, great watch.

    http://www.kelleydrye.com/news/press/0170

    How about this as an alternative to an ESD? Use the PCT rules in place, so that the attorney has to commission a search report through them if over the 25/5 claim limit? The US is already doing this for PCT applicants so there would not be many changes to be made. This would be a fee of $300 and because the PTO did it themselves there would be no admissions made by the attorney about what it contains.
    But the real reason is probably the same as my last post. Since Congress would take most of the extra income earned by this, the search report has to be done by someone else.

    I have it from a reliable source at the courthouse that Judge Carchesi granted the preliminary injunction this morning.

    Sorry, my previous message should have said Judge "Carcheris," not "Carchesi".

    re: Whealan's comments.

    Whealan has made this comments in other forums. What he fails to grasp is that the PTO is not entitled to make policy: Congress only granted to the PTO "tidying up" powers.

    No phones or blackberry's allowed! I think it was John White two people behind me who almost cried when I was stopped with my cell phone.

    Verify your Comment

    Previewing your Comment

    This is only a preview. Your comment has not yet been posted.

    Working...
    Your comment could not be posted. Error type:
    Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

    The letters and numbers you entered did not match the image. Please try again.

    As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

    Having trouble reading this image? View an alternate.

    Working...

    Post a comment

    Comments are moderated, and will not appear until the author has approved them.

    August 2010

    Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5 6 7
    8 9 10 11 12 13 14
    15 16 17 18 19 20 21
    22 23 24 25 26 27 28
    29 30 31        

    Google Search


    Patent Search

    • Patent Search
      FreePatentsOnline.com

      Advanced Patent Search